Depression News and Research

Latest Depression News and Research

Pet dog decreases risk of obesity in kids: Study

According to the latest research in England, children who have a dog for a pet are less likely to be obese. Children who are obese in childhood are at increased risk of developing a range of chronic health problems such as high blood pressure, high cholesterol levels, bone and joint problems, asthma, disrupted sleep patterns, liver and gall bladder disease, early physical maturity and depression.

23 Sep 2010

People's Care ranks #2140 on Inc. 5000 list of fastest growing private companies

Inc. Magazine included Southern California-based People's Care in its fourth annual Inc. 5000, an exclusive ranking of the country's fastest growing private companies. The list represents a comprehensive look at an important segment of the United States' economy: independent entrepreneurs. People's Care joins other prominent brands on the list, including music website Pandora, 7-Eleven and Radio Flyer.

23 Sep 2010

Biogen Idec concurs with FDA on safety monitoring for Gilenya through REMS

Biogen Idec is committed to improving the lives of people with multiple sclerosis (MS), and no company is doing more for these patients. There has been a desire within the MS community for an oral treatment for a long time, and the approval of Gilenya has made this a reality.

23 Sep 2010

Evotec AG collaborates with Almirall for ion channel validation in respiratory diseases

Evotec AG today announced that it has entered into a collaboration with Almirall S.A. to identify small molecule modulators of an ion channel target, selected by Almirall, involved in respiratory diseases.

23 Sep 2010

Male partners of women with breast cancer at increased risk of developing mood disorders

A new analysis finds that men whose partners have breast cancer are at increased risk of developing mood disorders that are so severe that they warrant hospitalization. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study indicates that clinicians should address the mental health of cancer patients' loved ones.

23 Sep 2010

Novartis' SOM230 reduces cortisol levels in Cushing's disease patients

Novartis Pharmaceuticals Corporation announced today that the results of a Phase III study of SOM230 (pasireotide) showed a reduction in cortisol levels in patients with Cushing's disease, a condition in which a benign (non-cancerous) pituitary tumor causes the adrenal glands to produce excess cortisol and can be fatal. Results will be presented at the 14th Congress of the European Neuroendocrine Association (ENEA).

22 Sep 2010

ACT people live longer but may have more mental health issues: Report

Chief Health Officer Charles Guest's report on the health and wellbeing of the Australian Capital Territory (ACT) population between July 2006 and June 2008 was presented in the Legislative Assembly. It showed that life expectancy rate at birth in the ACT was 80.3 years for males and 84 for women. This was despite the fact that most are overweight and only a minority eats enough fruit and vegetables.

22 Sep 2010

Fatty issues

In a new survey it was seen that too fat and too thin people suffer more from depressive moods. The Gallup-Healthways Well-Being Index published these findings it its September 17 issue and noted obese and underweight Americans are more stressed, worried, angry and sad than their overweight and normal weight friends.

22 Sep 2010

Specific orofacial characteristics can lead to accurate diagnosis of fetal alcohol spectrum disorders

Fetal alcohol spectrum disorders (FASD) is an umbrella term that describes the range of effects that can occur in a person whose mother drank alcohol while pregnant. Each year, FASD affect an estimated 40,000 infants in the United States—more than spina bifida, Down syndrome, and muscular dystrophy combined.

22 Sep 2010

VIVUS announces QNEXA study results for obesity treatment

VIVUS, Inc. today announced positive top-line results from a two-year study of QNEXA(phentermine/topiramate) Controlled Release Capsules, an investigational therapy for treatment of obesity, a condition that affects approximately one-third of adult Americans.

21 Sep 2010

Young victims of cyber bullying more likely to suffer from depression

Young victims of electronic or cyber bullying — which occurs online or by cell phone — are more likely to suffer from depression than their tormentors are, a new study finds.

21 Sep 2010

Voice disorders are not benign nuisances that go away

Two-thirds of Americans with voice problems don't seek medical care either because they don't know treatment is available or because they think the problem will just go away, according to a new study conducted at the Duke Voice Care Center.

21 Sep 2010

Haven Behavioral Hospital offers treatment programs for adults with psychiatric illnesses

Haven Behavioral Hospital of Eastern Pennsylvania announced today it is offering acute intensive, inpatient and partial day treatment programs for adults with major psychiatric illnesses. The hospital will operate within the downtown campus of St. Joseph Medical Center and will offer services for adults suffering from schizophrenia, bipolar disorder, depression and anxiety disorders.

21 Sep 2010

Arrayit installs microarray platform at NIH

Arrayit Corporation has completed installation and technical training of its proprietary microarray platform at the National Institute of Mental Health, National Institutes of Health, in Rockville, Maryland. In 2010, the NIH will invest more than $31.2 billion in medical research for the American people through 50,000 competitive grants to 325,000 researchers at 3,000 universities, hospitals, companies, medical schools and scientific institutions in the United States and around the world.

21 Sep 2010

Medicare receives increased scrutiny regarding fraud, payment issues

USA Today: "Proposed regulations being unveiled today seek to crack down on Medicare and Medicaid fraud by subjecting operators of certain medical firms to fingerprinting and stopping payments when credible fraud allegations are made, documents show. The rules would give federal health officials key powers to identify fraud early and reduce the estimated $55 billion in improper payments made each year in the Medicare and Medicaid programs, said Peter Budetti, director of the new anti-fraud office at the federal Centers for Medicare & Medicaid Services" (Young, 9/20).

20 Sep 2010

Adenovirus exposure may cause obesity in children: Study

The emerging idea that obesity may have an infectious origin gets new support in a cross-sectional study by University of California, San Diego School of Medicine researchers who found that children exposed to a particular strain of adenovirus were significantly more likely to be obese.

20 Sep 2010

AMDAI launches 'Don't Surrender to AMD' public awareness campaign

Age-related Macular Degeneration (AMD), which affects more than 10 million older Americans, continues to be the leading cause of vision loss in the United States. The global cost of the disease according to a recent report by AMD Alliance International (AMDAI) is estimated at $343 billion, underscoring the need for swift actions to raise awareness of prevention and treatment options.

18 Sep 2010

Investigators uncover new insights on adolescent fighting

UT Southwestern Medical Center investigators have uncovered new insights on adolescent fighting: what triggers it, and how to stem it. Varied real-life factors pile on daily to put teens on edge: destructive behaviors like drug abuse, drinking or high-risk sexual encounters; poverty; academic troubles; and even depression. Data analyzed by researchers at UT Southwestern suggests that when teens perceive support from their families and/or schools, it can help mitigate violence.

17 Sep 2010

WHO urges development programs to include mental and psychosocial disabled patients

People with mental and psychosocial disabilities are among the most marginalized groups in developing countries. Even though development actors have pledged to focus their work on the most vulnerable in a community, many programmes continue to ignore and exclude this vulnerable group.

17 Sep 2010

FDA Advisory Committee recommends approval of Alkermes' VIVITROL for opioid dependence

Alkermes, Inc. today announced that the U.S. Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee voted 12 to 1 that VIVITROL® (naltrexone for extended-release injectable suspension) should be approved for the treatment of opioid dependence.

17 Sep 2010